
    
      Single-centre, open-label, parallel group, non-randomised study in 12 healthy elderly and 12
      healthy younger male subjects, who participated in 2 consecutive phases:

      Phase A: a single-dose phase (including a wash out period); Phase B: a multiple-dose phase
      during 7 days (steady state).
    
  